Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Ocaratuzumab [USAN:INN]
RN: 1169956-08-4


  • An anti-CD20 antibody for treatment of cancer in phase I/II clinical trials (2010).

Molecular Formula

  • C6464-H10016-N1712-O2010-S44

Classification Code

  • Treatment of Cancer
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Ocaratuzumab [USAN:INN]


  • AME 133v
  • AME-133v
  • Immunoglobulin G1, anti-(human B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1, Bp35, leukocyte surface antigen Leu-16, membrane-spanning 4-domains subfamily A member 1))
  • LY 2469298
  • LY2469298
  • Ocaratuzumab
  • UNII-NTY9893GD0

Systematic Name

  • Humanized mouse monoclonal des-Lys(sup451)-gamma 1 heavy chain (224-213')-disulfide with humanized mouse monoclonal kappa light chain dimer (230-230'':233-233'')-bisdisulfide

Registry Numbers

CAS Registry Number

  • 1169956-08-4


  • NTY9893GD0

System Generated Number

  • 1169956084